Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,523,000 | 5,606,000 | 6,193,000 | 2,418,000 | 3,941,000 |
| Depreciation Amortization | 3,486,000 | 3,310,000 | 4,519,000 | 4,676,000 | 5,471,000 |
| Income taxes - deferred | -566,000 | -560,000 | -509,000 | -2,621,000 | -1,521,000 |
| Accounts receivable | -1,002,000 | 92,000 | -418,000 | 297,000 | -619,000 |
| Accounts payable and accrued liabilities | 684,000 | 443,000 | 230,000 | 254,000 | 278,000 |
| Other Working Capital | -4,601,000 | -2,077,000 | -1,553,000 | -5,017,000 | -2,601,000 |
| Other Operating Activity | 5,093,000 | 2,070,000 | 2,460,000 | 6,444,000 | 5,427,000 |
| Operating Cash Flow | $7,617,000 | $8,884,000 | $10,922,000 | $6,451,000 | $10,376,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,717,000 | 5,420,000 | 7,258,000 | 4,925,000 | -1,298,000 |
| PPE Investments | -4,429,000 | -3,369,000 | -2,615,000 | -1,888,000 | -1,614,000 |
| Net Acquisitions | -6,606,000 | -4,954,000 | -431,000 | -396,000 | -780,000 |
| Other Investing Activity | -875,000 | 374,000 | 102,000 | 38,000 | 482,000 |
| Investing Cash Flow | $-9,193,000 | $-2,529,000 | $4,314,000 | $2,679,000 | $-3,210,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,549,000 | -3,710,000 | 5,124,000 | -26,000 | 0 |
| Debt Issued | 4,419,000 | 4,958,000 | N/A | N/A | 1,079,000 |
| Debt Repayment | -1,957,000 | N/A | -4,287,000 | -1,103,000 | -2,386,000 |
| Common Stock Issued | 89,000 | 361,000 | 591,000 | 499,000 | 939,000 |
| Common Stock Repurchased | -1,281,000 | -4,780,000 | -9,091,000 | -4,014,000 | -3,434,000 |
| Dividend Paid | -6,215,000 | -5,695,000 | -5,172,000 | -5,167,000 | -5,124,000 |
| Other Financing Activity | -436,000 | 5,000 | -325,000 | -195,000 | -118,000 |
| Financing Cash Flow | $-2,832,000 | $-8,861,000 | $-13,160,000 | $-10,006,000 | $-9,044,000 |
| Exchange Rate Effect | 253,000 | 17,000 | -205,000 | 457,000 | -131,000 |
| Beginning Cash Position | 9,934,000 | 7,967,000 | 6,096,000 | 6,515,000 | 8,524,000 |
| End Cash Position | 8,165,000 | 9,934,000 | 7,967,000 | 6,096,000 | 6,515,000 |
| Net Cash Flow | $-1,769,000 | $1,967,000 | $1,871,000 | $-419,000 | $-2,009,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,617,000 | 8,884,000 | 10,922,000 | 6,451,000 | 10,376,000 |
| Capital Expenditure | -4,429,000 | -3,369,000 | -2,615,000 | -1,888,000 | -1,614,000 |
| Free Cash Flow | 3,188,000 | 5,515,000 | 8,307,000 | 4,563,000 | 8,762,000 |